Total Payments
$5,209
2024 Payments
$733.00
Companies
19
Transactions
158
Medicare Patients
1,329
Medicare Billing
$626,963
Payment Breakdown by Category
Food & Beverage$5,149 (98.8%)
Education$59.98 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,149 | 156 | 98.8% |
| Education | $59.98 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,927 | 41 | $0 (2022) |
| Alkermes, Inc. | $495.03 | 20 | $0 (2024) |
| ITI, Inc. | $425.99 | 10 | $0 (2023) |
| Allergan, Inc. | $405.20 | 10 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $338.79 | 8 | $0 (2024) |
| Lundbeck LLC | $274.14 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $256.69 | 14 | $0 (2024) |
| ABBVIE INC. | $225.09 | 9 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $201.95 | 5 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $147.14 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $733.00 | 31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($201.95) |
| 2023 | $584.68 | 26 | ABBVIE INC. ($173.40) |
| 2022 | $490.34 | 19 | ITI, Inc. ($254.44) |
| 2021 | $217.47 | 6 | Alkermes, Inc. ($125.00) |
| 2020 | $259.26 | 7 | Sunovion Pharmaceuticals Inc. ($126.46) |
| 2019 | $1,150 | 24 | Sunovion Pharmaceuticals Inc. ($654.22) |
| 2018 | $944.28 | 23 | Sunovion Pharmaceuticals Inc. ($547.67) |
| 2017 | $829.93 | 22 | Sunovion Pharmaceuticals Inc. ($472.03) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $15.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/14/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: CNS | ||||||
| 07/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Neuropsychiatry | ||||||
| 07/26/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $18.63 | General |
| Category: PSYCHIATRY | ||||||
| 07/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: CNS | ||||||
| 06/28/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: BH | ||||||
| 06/21/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $13.67 | General |
| Category: PSYCHIATRY | ||||||
| 06/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $84.27 | General |
| Category: Neuroscience | ||||||
| 05/29/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Neuropsychiatry | ||||||
| 04/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: PSYCHIATRY | ||||||
| 03/26/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: BH | ||||||
| 03/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 281 | 1,953 | $274,260 | $185,634 |
| 2022 | 3 | 332 | 1,819 | $248,025 | $153,565 |
| 2021 | 5 | 344 | 1,692 | $232,780 | $146,883 |
| 2020 | 5 | 372 | 1,555 | $217,300 | $140,880 |
Total Patients
1,329
Total Services
7,019
Medicare Billing
$626,963
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 142 | 1,760 | $231,660 | $164,358 | 70.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 68 | 91 | $27,300 | $12,058 | 44.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 71 | 102 | $15,300 | $9,219 | 60.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 168 | 1,617 | $202,125 | $129,670 | 64.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 87 | 104 | $31,200 | $15,692 | 50.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 77 | 98 | $14,700 | $8,203 | 55.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 139 | 1,457 | $182,650 | $119,969 | 65.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 84 | 93 | $27,900 | $14,094 | 50.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 94 | 109 | $16,350 | $9,349 | 57.2% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2021 | 12 | 18 | $2,920 | $1,797 | 61.5% |
| 99326 | New patient assisted living visit, typically 45 minutes | Office | 2021 | 15 | 15 | $2,960 | $1,675 | 56.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 165 | 1,321 | $164,625 | $112,321 | 68.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 97 | 110 | $33,000 | $17,057 | 51.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 82 | 96 | $14,400 | $8,424 | 58.5% |
| 99326 | New patient assisted living visit, typically 45 minutes | Office | 2020 | 15 | 15 | $3,000 | $1,705 | 56.8% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2020 | 13 | 13 | $2,275 | $1,373 | 60.3% |
About Dr. Alexander Jacobson, M.D
Dr. Alexander Jacobson, M.D is a Psychiatry healthcare provider based in Newark, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639199169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Jacobson, M.D has received a total of $5,209 in payments from pharmaceutical and medical device companies, with $733.00 received in 2024. These payments were reported across 158 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($5,149).
As a Medicare-enrolled provider, Jacobson has provided services to 1,329 Medicare beneficiaries, totaling 7,019 services with total Medicare billing of $626,963. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Newark, DE
- Active Since 07/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639199169
Products in Payments
- LATUDA (Drug) $1,927
- VRAYLAR (Drug) $630.29
- CAPLYTA (Drug) $627.94
- ARISTADA (Drug) $346.79
- ABILIFY MAINTENA (Drug) $284.55
- REXULTI (Drug) $202.98
- INVEGA SUSTENNA (Drug) $166.53
- NUEDEXTA (Drug) $147.14
- LYBALVI (Drug) $125.00
- FARXIGA (Drug) $124.99
- INGREZZA (Drug) $124.73
- Auvelity (Drug) $87.91
- INVEGA (Drug) $84.27
- INVEGA TRINZA (Drug) $69.28
- ABILIFY ASIMTUFII (Drug) $63.45
- PERSERIS (Drug) $50.81
- SD809-TD (Drug) $32.78
- FreeStyle Libre 2 (Device) $24.06
- Aristada 441 mg (Drug) $23.24
- COBENFY (Drug) $20.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Newark
Dr. Sun Young Yum, M.d, M.D
Psychiatry — Payments: $68,623
Psychiatry $68,623
Dr. Dilipkumar Joshi, M.d, M.D
Psychiatry — Payments: $6,570
Psychiatry $6,570
Jeet Joshi, M.d, M.D
Psychiatry — Payments: $4,502
Psychiatry $4,502
Dr. Tobechukwu Clouden, Md, MD
Psychiatry — Payments: $2,960
Psychiatry $2,960
Dr. Richard Black, Md, MD
Psychiatry — Payments: $2,374
Psychiatry $2,374
Frank Ostella, D.o, D.O
Psychiatry — Payments: $1,969
Psychiatry $1,969